Search results for "Cardiovascular Disease"

Results 101 - 110 of about 355 for "Cardiovascular Disease".

New warnings added on multiple diabetes drugs

familial hypercholesterolemia, homozygous familial hypercholesterolemia, or clinical atherosclerotic cardiovascular disease who require additional lowering of LDL cholesterol.
November 2015

Diabetes care

The study also showed that intensive glycemic control can have a positive effect on retinopathy, even in type 2 diabetics who are at high risk of cardiovascular disease.
July 2010

Take a tiered approach to CVD Image by AlexSecret. Primary care physicians' efforts are paying off as they promote primary prevention of cardiovascular disease, ... Cardiovascular disease (CVD) claims more
February 2022

Warning on medication confusion, recalls due to sterility

Alirocumab (Praluent) injection to treat heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in addition to diet and maximally tolerated statin therapy.
October 2015

Two-pronged plan to attack prediabetes

be used in higher risk patients, such as those with two out of three of the diagnostic criteria (IFG, IGT, metabolic syndrome) or worsening glycemia, cardiovascular disease, nonalcoholic fatty liver disease, ... family history of diabetes,.
October 2008


statins than with other drugs commonly used for cardiovascular disease. ... The rate of cognitive-related adverse events in the FDA postmarketing databases was low for statins and was similar to rates reported for other common cardiovascular drugs.
November 2013


mm Hg in patients with diabetes or renal disease) and smoking (which should be addressed at every patient encounter). ... other established cardiovascular disease.
December 2010


population's cardiovascular health status. The AHA report also set a goal of improving Americans' cardiovascular health by 20% and reducing deaths from cardiovascular disease and stroke by 20% by the ... Using the Coronary Heart Disease Policy Model,
January 2010


Taking NSAIDs increases cardiovascular risk for heart attack survivors as long as five years after the attack, a new study found. ... It would seem prudent to limit NSAID use among patients with cardiovascular disease and to get the message out to
September 2012


After adjustment for variables including traditional risk factors, patients in the CBT group were 41% less likely to have a recurrent cardiovascular disease event (hazard ratio, 0.59; 95% CI, ... There was also a strong dose-response effect between
February 2011

Prev   6   7   8   9   10   11   12   13   14   15   Next